This site uses cookies to ensure the best viewing experience for our readers. Read more about it Got it

Ophectra Signs Merger Deal With Meat Bioprinting Company MeaTech

The announcement comes a week after Ophectra announced that its merger deal with cannabis company Hi Pharma fell through

Ori Galor and Tzally Greenberg 12:4303.10.19
Israeli real estate and holding company Ophectra Real Estate & Investments Ltd. announced on Wednesday a merger memorandum of understanding with MeaTech Ltd., a company developing technology for bioprinting meat using stem cells. Following the merger, MeaTech’s founders will hold 60% of the merged entity, as well as options for an additional 8%. The final agreement is expected to be signed within 45 days following due diligence processes.

 

The announcement comes a week after Ophectra announced that its merger deal with cannabis company Hi Pharma Ltd. fell through.

 

Meat (illustration). Photo: Amit Sha'al Meat (illustration). Photo: Amit Sha'al

 

 

MeaTech was incorporated in 2018 and has been operational for almost a year. The company has five employees but expects to recruit another 10 soon, co-founder and CEO Sharon Fima told Calcalist in an interview. The company is hoping to achieve a viable prototype within a year. Merging with Ophectra will offer Meatech more fundraising options, he said. The company recently raised NIS 7 million ($2 million) in a seed investment round.
Cancel Send
    To all comments